GAMCO Investors’s Avidity Biosciences RNAM Stock Holding History

GAMCO Investors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,500	Closed	-$252K	–	1058
2025 Q4	$252K	Buy	+3,500	New	+$226K	﹤0.01%	959

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

GAMCO Investors's RNAM Position: Q1 2026 in Review

GAMCO Investors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,500 shares — an estimated $252K sold.

GAMCO Investors first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $252K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

GAMCO Investors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
GAMCO Investors sold 3,500 Avidity Biosciences shares in Q1 2026, an estimated $252K.
GAMCO Investors first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
GAMCO Investors's Avidity Biosciences position peaked at $252K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.